Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake

European Journal of Nuclear Medicine

Volumn 29, Issue 4, 2002, Pages 480-485

  Reinhardt, Michael J ^a   Joe, Alexius ^b   Von Mallek, Dirk ^a   Zimmerlin, Martina ^b   Manka Waluch, Agnieszka ^a   Palmedo, Holger ^a   Krause, Thomas M ^c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Diffuse toxic goitre; Dose calculation; Nodular toxic goitre; Radioiodine therapy

Indexed keywords

PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; THYROTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DOSIMETRY; DRUG UPTAKE; FEMALE; FOLLOW UP; HORMONAL THERAPY; HORMONE URINE LEVEL; HUMAN; HYPERTHYROIDISM; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; RADIATION ABSORPTION; RADIATION DOSE; RECURRENT DISEASE; THYROID WEIGHT; TOXIC GOITER; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SODIUM PERTECHNETATE TC 99M; STATISTICS, NONPARAMETRIC; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0036207922     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0722-0     Document Type: Article

References (30)

1. Optimization of radioiodine therapy of thyrotoxicosis: What have we learned after 50 years?
2. Radioiodine therapy of hyperthyroidism
3. Optimized dose planning of radioiodine therapy of benign thyroidal diseases
4. Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses
5. Results of the definitive treatment of autonomy in iodine deficient goiter
6. Results of radioiodine therapy of manifest hyperthyroidism and autonomous goiter with euthyroidism
7. 99mTc-pertechnetate
8. Determination of the autonomously functioning volume of the thyroid
9. Improved dose concept for radioiodine therapy of multifocal and disseminated thyroid autonomy
10. s-adapted dose concept
11. Influence of urinary iodine excretion on thyroid technetium-99m pertechnetate uptake with and without TSH suppression: What happens when iodine supply increases?
12. Biochemical evaluation of iodine status
13. Volumetrie der schilddrüsenlappen mittels real-time-sonography
14. 99mTc-thyroid uptake test in thyroid diagnostics
15. Bestimmung der harnjodausscheidung mittels einer modifizierten cer-arsenitmethode
16. Rapid urinary iodine test
17. Dosage determination with radioactive isotopes. Practical considerations in therapy and protection
18. The autonomous functioning thyroid nodule in the evolution of nodular goiter
19. Pathogenesis of thyroid nodules in multinodular goiter
20. Pathogenesis of heterogeneity in human multinodular goiter
21. Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate
22. Radioiodine therapy of functional autonomy using the functional autonomous volume
23. s-optimized radioiodine therapy of multifocal and disseminated functional thyroid autonomy
24. Radioiodine treatment of hyperthyroidism - Prognostic factors for outcome
25. Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine
26. Long-term results of two schedules of radioiodine treatment for toxic multinodular goitre
27. Outpatient management of patients with large multinodular goiters treated with fractionated radioiodine
28. Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole
29. Two-step radioiodine therapy in benign thyroid diseases during a single hospital visit - Observation on 100 patients
30. The importance of radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases